Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PHRRF |
---|---|---|
09:32 ET | 4900 | 0.15 |
09:42 ET | 500 | 0.155 |
10:15 ET | 4675 | 0.1649 |
10:51 ET | 5000 | 0.15975 |
11:32 ET | 5000 | 0.1612 |
12:01 ET | 100 | 0.15975 |
12:15 ET | 100 | 0.16225 |
12:46 ET | 2000 | 0.16225 |
12:55 ET | 4000 | 0.16 |
01:45 ET | 22500 | 0.162 |
03:03 ET | 45024 | 0.16 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pharmather Holdings Ltd | 19.0M | --- | --- |
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 88.5M |
Pharmather Holdings Ltd does not pay a dividend. | |
Beta | 3.34 |
EPS | $-0.02 |
Book Value | $0.03 |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.